Clinical Evaluation of Moment Tumor Hip Replacement Products

Inclusion Criteria: * Adults of both sexes aged 18-79 years * For patients with bone loss, fractures, pseudarthrosis due to primary-secondary metastases in the hip femoral region, patients belonging to one or more of the following groups * Patients with or with bone resections due to infection * Patients with unsuccessful femoral component applications * Patients in need of long-term stabilization of major bone defects caused by fractures with major and irreversible bone loss, periprosthetic fractures, traumatic non-tumor conditions affecting the trunks of the long bones, and comminuted fractures * Patients with severe pain and loss of function in the proximal femoral region * Patients with incompetence of the upper end of the femur or femoral neck fracture in hip replacement revisions. * Have sufficient mental and physical capacity to sign the informed consent form for the procedure Exclusion Criteria: * Be under the age of 18 and over the age of 79 * Pregnancy * Breastfeeding * Patients with bone tumors near the implant * Patients with acute or chronic infections (local or systemic) that reduce the adhesion resistance of the implant. * Patients with defective bone structures that may prevent proper fixation of the implant and severe deterioration or axial deviation affecting bone quality * Patients with inadequate bone quantity and quality as a result of osteoporosis * Patients with underdeveloped skeletal structure * Patients with vascular and neuromuscular disorders or…